ENDLYZ THERAPEUTICS, INC.

Profile

Company Names

ENDLYZ THERAPEUTICS, INC.

Addresses

28 STATE STREET, BOSTON, MA 02109

C/O SV HEALTH INVESTORS, LLC, ONE BOSTON PL., 201 WASHINGTON ST. #3900, BOSTON, MA 02108

Phone Numbers

44 (0)7436124195
617-945-4074

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$20,500,395.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2026-03-31 
$17,250,395.00 
$19,650,393.00 
$2,399,998.00 
Equity 
1
2021-07-16 
$3,250,000.00 
$6,500,000.00 
$3,250,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LAURENCE 
 
BARKER 
DIRECTOR
DEMENTIA DISCOVERY LP   |  THERINI BIO, INC.   |  DEMENTIA DISCOVERY FUND 2 LP   |  ENDLYZ THERAPEUTICS, INC.
JONATHAN 
 
BEHR 
DIRECTOR
IMMUNOMOLECULAR THERAPEUTICS, INC.   |  VERALOX THERAPEUTICS INC.   |  NITROME BIOSCIENCES, INC   |  QURALIS CORP   |  ENDLYZ THERAPEUTICS, INC.   |  DEMENTIA DISCOVERY FUND 2 LP   |  VIOLET THERAPEUTICS, INC.
DAMIAN 
 
CROWTHER 
DIRECTOR
ENDLYZ THERAPEUTICS, INC.
TIMOTHY 
 
EDWARDS 
DIRECTOR
ENDLYZ THERAPEUTICS, INC.
JUSTIAN 
CRAIG 
FOX 
DIRECTOR
ENDLYZ THERAPEUTICS, INC.
JOHN 
 
GUSTOFSON 
DIRECTOR
RIBOMETRIX, INC.   |  ENDLYZ THERAPEUTICS, INC.   |  HYKU BIOSCIENCES INC.
ZAVEN 
 
KAPRIELIAN 
EXECUTIVE OFFICER, DIRECTOR
ENDLYZ THERAPEUTICS, INC.
DONMIENNE 
 
LEUNG 
DIRECTOR
EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC   |  ENDLYZ THERAPEUTICS, INC.
JOANNA 
 
WOLAK 
EXECUTIVE OFFICER, DIRECTOR
ENDLYZ THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2026-03-31 
2021-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#